ExodusPoint Capital Management’s Astrana Health ASTH Stock Holding History

ExodusPoint Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$470K	Sell	19,151 -80,813	-81%	-$1.91M	﹤0.01%	1204
2025 Q4	$2.48M	Buy	+99,964	New	+$2.65M	0.02%	704
2025 Q3	–	Sell	-8,075	Closed	-$201K	–	2100
2025 Q2	$201K	Sell	8,075 -18,015	-69%	-$507K	﹤0.01%	1315
2025 Q1	$809K	Sell	26,090 -10,060	-28%	-$335K	0.01%	971
2024 Q4	$1.14M	Buy	+36,150	New	+$1.72M	0.01%	906
2023 Q1	–	Sell	-14,499	Closed	-$429K	–	2185
2022 Q4	$429K	Sell	14,499 -26,373	-65%	-$848K	0.01%	1234
2022 Q3	$1.59M	Buy	+40,872	New	+$1.87M	0.02%	908
2020 Q4	–	Sell	-20,361	Closed	-$365K	–	2449
2020 Q3	$365K	Buy	+20,361	New	+$351K	0.01%	1183
2020 Q1	–	Sell	-16,987	Closed	-$313K	–	1721
2019 Q4	$313K	Buy	+16,987	New	+$282K	0.01%	1129
2019 Q2	–	Sell	-11,352	Closed	-$208K	–	1366
2019 Q1	$208K	Buy	+11,352	New	+$218K	0.02%	552

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ExodusPoint Capital Management's ASTH Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Astrana Health (ASTH) stake by 81% in Q1 2026, selling an estimated $1.91M and leaving 19,151 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1204.

ExodusPoint Capital Management first reported a position in ASTH in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.48M in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

ExodusPoint Capital Management held 19,151 shares of Astrana Health worth $470K as of Q1 2026.
ExodusPoint Capital Management sold 80,813 Astrana Health shares in Q1 2026, an estimated $1.91M.
Astrana Health made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1204 holding.
ExodusPoint Capital Management first reported a position in Astrana Health in Q1 2019 and has held it in 10 quarters since.
ExodusPoint Capital Management's Astrana Health position peaked at $2.48M in Q4 2025.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.